STM* (STM): Regulation changes…demand doesn’t (CORP) | Mortice* (MORT): Forecast upgrade and target price increase (CORP) | OptiBiotix* (OPTI): A sweet opportunity (CORP) | Amino Technologies* (AMO): Gross margin strength (CORP) | Altitude (ALT): Senior management appointment (CORP)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
STM Group PLC (STM:LON), 57.5 | OptiBiotix Health PLC (OPTI:LON), 18.0
- Published:
11 Jul 2017 -
Author:
Andrew Darley | Mark Paddon | Mark Brewer | Cavendish Research -
Pages:
7
STM* (STM): Regulation changes…demand doesn’t (CORP) | Mortice* (MORT): Forecast upgrade and target price increase (CORP) | OptiBiotix* (OPTI): A sweet opportunity (CORP) | Amino Technologies* (AMO): Gross margin strength (CORP) | Altitude (ALT): Senior management appointment (CORP)